心房颤动与炎症
Atrial fibrillation and inflammation.
作者信息
Ozaydin Mehmet
机构信息
Mehmet Ozaydin, Department of Cardiology, School of Medicine, Suleyman Demirel University, 32040, Isparta, Turkey.
出版信息
World J Cardiol. 2010 Aug 26;2(8):243-50. doi: 10.4330/wjc.v2.i8.243.
Abstract
Atrial fibrillation (AF) is the most common clinical arrhythmia. Recent investigations have suggested that inflammation might have a role in the pathophysiology of AF. In this review, the association between inflammation and AF, and the effects of several agents that have anti-inflammatory actions, such as statins, polyunsaturated fatty acids, corticosteroids and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, have been investigated.
摘要
心房颤动（AF）是最常见的临床心律失常。最近的研究表明，炎症可能在AF的病理生理学中起作用。在本综述中，研究了炎症与AF之间的关联，以及几种具有抗炎作用的药物的效果，如他汀类药物、多不饱和脂肪酸、皮质类固醇以及血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂。
相似文献
1
Atrial fibrillation and inflammation.心房颤动与炎症
World J Cardiol. 2010 Aug 26;2(8):243-50. doi: 10.4330/wjc.v2.i8.243.
2
Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance.他汀类药物和多不饱和脂肪酸在心房颤动的一级和二级预防中的作用：证据回顾与临床相关性。
Naunyn Schmiedebergs Arch Pharmacol. 2010 Mar;381(3):1-13. doi: 10.1007/s00210-009-0468-y. Epub 2009 Nov 25.
3
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.心房颤动管理的上游治疗：临床证据回顾及其对欧洲心脏病学会指南的影响。第一部分：一级预防。
Europace. 2011 Mar;13(3):308-28. doi: 10.1093/europace/eur002.
4
Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.用于治疗心房颤动的他汀类药物和多不饱和脂肪酸
Nat Clin Pract Cardiovasc Med. 2008 Jan;5(1):30-41. doi: 10.1038/ncpcardio1038.
5
Update on the association of inflammation and atrial fibrillation.炎症与心房颤动相关性的研究进展。
J Cardiovasc Electrophysiol. 2010 Sep;21(9):1064-70. doi: 10.1111/j.1540-8167.2010.01774.x.
6
Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.使用血管紧张素转换酶抑制剂、血管紧张素 II 受体阻滞剂和他汀类药物进行治疗：对房颤消融术后的消融结果无影响。
Am Heart J. 2007 Jan;153(1):113-9. doi: 10.1016/j.ahj.2006.09.006.
7
The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.他汀类药物和肾素-血管紧张素系统阻滞剂对肺静脉前庭隔离术后房颤复发的影响。
J Cardiovasc Electrophysiol. 2007 Sep;18(9):942-6. doi: 10.1111/j.1540-8167.2007.00887.x. Epub 2007 Jun 25.
8
[Upstream therapy of atrial fibrillation in patients with heart failure].[心力衰竭患者心房颤动的上游治疗]
G Ital Cardiol (Rome). 2009 Sep;10(9):566-71.
9
Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction.ST段抬高型心肌梗死患者使用肾素-血管紧张素系统阻滞剂与院内房颤发生之间的关联。
Medicina (Kaunas). 2016;52(2):104-9. doi: 10.1016/j.medici.2016.02.006. Epub 2016 Mar 11.
10
Non-antiarrhythmic drugs to prevent atrial fibrillation.非抗心律失常药物预防心房颤动。
Am J Cardiovasc Drugs. 2010;10(3):165-73. doi: 10.2165/11537270-000000000-00000.
引用本文的文献
1
The CHA2DS2-VASc score for predicting atrial fibrillation in patients presenting with ST elevation myocardial infarction: prospective observational study.CHA2DS2-VASc评分预测ST段抬高型心肌梗死患者房颤发生情况：前瞻性观察研究
Sao Paulo Med J. 2019 Jul 22;137(3):248-254. doi: 10.1590/1516-3180.2018.0431140319.
2
Time Series Gene Expression Profiling and Temporal Regulatory Pathway Analysis of Angiotensin II Induced Atrial Fibrillation in Mice.小鼠中血管紧张素II诱导的心房颤动的时间序列基因表达谱分析及时间调控通路分析
Front Physiol. 2019 May 29;10:597. doi: 10.3389/fphys.2019.00597. eCollection 2019.
3
Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion.利钠肽作为电复律后房颤复发的预测指标
Arrhythm Electrophysiol Rev. 2013 Nov;2(2):109-14. doi: 10.15420/aer.2013.2.2.109. Epub 2013 Nov 29.
4
Looking into a conceptual framework of ROS-miRNA-atrial fibrillation.探究活性氧-微小核糖核酸-心房颤动的概念框架。
Int J Mol Sci. 2014 Nov 26;15(12):21754-76. doi: 10.3390/ijms151221754.
5
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).强化血糖控制对2型糖尿病患者房颤发病率及相关心血管结局的影响（来自糖尿病心血管风险控制行动研究）
Am J Cardiol. 2014 Oct 15;114(8):1217-22. doi: 10.1016/j.amjcard.2014.07.045. Epub 2014 Jul 30.
6
Airflow obstruction, lung function, and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.气流阻塞、肺功能与心房颤动的发生：动脉粥样硬化风险社区研究（ARIC）。
Circulation. 2014 Mar 4;129(9):971-80. doi: 10.1161/CIRCULATIONAHA.113.004050. Epub 2013 Dec 16.
7
TLR2 was overexpressed independent of IL-6 in patients with valvular atrial fibrillation.在瓣膜性心房颤动患者中，Toll样受体2（TLR2）的过度表达与白细胞介素-6无关。
J Biomed Res. 2011 May;25(3):178-84. doi: 10.1016/S1674-8301(11)60023-7.
本文引用的文献
1
Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.轻度和中度左心室功能不全患者中肾素-血管紧张素-醛固酮系统阻滞剂与术后心房颤动的关联
Anadolu Kardiyol Derg. 2010 Apr;10(2):137-42. doi: 10.5152/akd.2010.039.
2
Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting.血管紧张素转换酶抑制剂疗法对接受冠状动脉旁路移植术患者临床结局的影响。
J Am Coll Cardiol. 2009 Nov 3;54(19):1778-84. doi: 10.1016/j.jacc.2009.07.008. Epub 2009 Aug 13.
3
Association between the use of non-antiarrhythmic drugs and postoperative atrial fibrillation.非抗心律失常药物的使用与术后心房颤动的关系。
Int J Cardiol. 2010 Oct 8;144(2):304-6. doi: 10.1016/j.ijcard.2009.02.029. Epub 2009 Mar 17.
4
The association between previous statin use and development of atrial fibrillation in patients presenting with acute coronary syndrome.既往他汀类药物使用与急性冠脉综合征患者心房颤动发展的相关性。
Int J Cardiol. 2010 May 28;141(2):147-50. doi: 10.1016/j.ijcard.2008.11.172. Epub 2008 Dec 23.
5
Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target.心房颤动中的氧化应激与炎症：在发病机制中的作用及作为治疗靶点的潜力
J Cardiovasc Pharmacol. 2008 Oct;52(4):306-13. doi: 10.1097/FJC.0b013e31817f9398.
6
Dose-related effect of statins on atrial fibrillation after cardiac surgery.他汀类药物对心脏手术后房颤的剂量相关效应。
Ann Thorac Surg. 2008 May;85(5):1515-20. doi: 10.1016/j.athoracsur.2008.01.040.
7
Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction.补充欧米伽-3脂肪酸可降低心肌梗死住院患者发生心房颤动的一年风险。
Eur J Clin Pharmacol. 2008 Jun;64(6):627-34. doi: 10.1007/s00228-008-0464-z.
8
Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials.他汀类药物治疗与心房颤动的抗心律失常作用：随机对照试验的荟萃分析
J Am Coll Cardiol. 2008 Feb 26;51(8):828-35. doi: 10.1016/j.jacc.2007.09.063.
9
Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery.术前他汀类药物治疗与心脏手术患者术后房颤发生率的降低无关。
Am Heart J. 2008 Mar;155(3):541-6. doi: 10.1016/j.ahj.2007.10.027. Epub 2007 Dec 19.
10
Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery.术前使用他汀类药物预防心胸外科手术后房颤
J Thorac Cardiovasc Surg. 2008 Feb;135(2):405-11. doi: 10.1016/j.jtcvs.2007.08.049.
Zotero 插件